About ProSolus Pharma
ProSolus Pharma is a Healthcare company based in Miami (United States) founded in 2009. Transdermal drug delivery systems are formulated, developed, and manufactured. The company has since been acquired. ProSolus Pharma offers products and services including Transdermal Patches and Topical Patches. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is ProSolus, Inc.
Company details
ProSolus Pharma was established in 2009 as a subsidiary of Mission Pharmacal Company in the pharmaceutical sector. High-barrier transdermal drug delivery systems are formulated, developed, and manufactured for ANDA, NDA, and 505(b)(2) applications. Services encompass stages from conceptualization to commercialization, including various transdermal patch capacities. Operations are based in Miami, United States.
- Headquarters Miami, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website prosoluspharma.com
- Social LinkedIn X Facebook
- Acquired by Mission Pharmacal (Jun 2015)
- Legal Name Prosolus, Inc.
- InvestorsMission Pharmacal
& 1 more
Products & Services of ProSolus Pharma
ProSolus Pharma offers a comprehensive portfolio of products and services, including Transdermal Patches and Topical Patches.
Patches for administering medications through the skin.
Formulations for skin application in therapeutic treatments.
Investors in ProSolus Pharma
ProSolus Pharma has secured backing from 1 investor. Prominent investors backing the company include Mission Pharmacal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceuticals and nutritional supplements are manufactured and marketed. | 1946 | missionpharmacal.com | San Antonio, United States |
Investor details for ProSolus Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ProSolus Pharma
2 dated milestones of ProSolus Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded ProSolus Pharma is founded.
- Exit Acquired by Mission Pharmacal.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ProSolus Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prosolus Pharma
Complete news archive for ProSolus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProSolus Pharma
ProSolus Pharma was founded in 2009.
ProSolus Pharma is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
ProSolus Pharma was established in 2009 as a subsidiary of Mission Pharmacal Company in the pharmaceutical sector. High-barrier transdermal drug delivery systems are formulated, developed, and manufactured for ANDA, NDA, and 505(b)(2) applications. Services encompass stages from conceptualization to commercialization, including various transdermal patch capacities. Operations are based in Miami, United States.
ProSolus Pharma offers Transdermal Patches and Topical Patches.
ProSolus Pharma has 1 investor. Key investors include Mission Pharmacal.
ProSolus Pharma operates through Prosolus, Inc..
Yes. ProSolus Pharma was acquired by Mission Pharmacal in June 2015.